EFPIA Issues Support for EU Anticounterfeit Measures

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 03-04-2014 10:02


The European Federation of Pharmaceutical Industries and Associations (EFPIA) issued its support for a vote by the European Parliament that enacted measures to address the transit of trademark counterfeit goods in the European Union (EU) as part trademark legislation.

According to EFPIA, since the Philips/Nokia Ruling (C446 and 495/09) in 2011, under EU law, European customs can check counterfeit goods transiting through the EU but can only stop them if there is a risk of these goods entering into the Single Market. “This means in practice that customs are powerless against counterfeit goods on route to a third country, and must let them go, at the risk of these goods being illegally diverted back into the EU,” said the EFPIA in a press statement.

The new provisions adopted will allow customs to stop trademark counterfeit goods even if destined to a country outside the EU and will not affect the trade of legitimate goods under the EU’s World Trade Organization (WTO) international obligations. ”Likewise, these provisions ensure that genuine generic medicines will reach their final destination,” said EFPIA.

According to EFPIA, trademark-intensive industries account for 21% of all direct jobs in the EU and for 34% of the EU gross domestic product. “The global trade of counterfeits has been growing exponentially and the lack of adequate rules at EU level has exacerbated the problem affecting companies, governments and citizens across Europe. Indeed, the 2012 detention statistics from EU customs have shown an unprecedented and extremely worrying fall by 65% on the year before. Without robust rules to stem the tide, the risk of the EU being a hub for the trade of counterfeits is real."

EFPIA continued in its statement: "We salute this vote and the political courage of MEPs Marielle Gallo and Bernhard Rapkay who sponsored the transit provisions…. With this vote, the European Parliament signals that it is serious about stopping trademark counterfeits to protect consumers everywhere and that the EU should show leadership in the global fight against counterfeiting.” 

Source: EFPIA





Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription